Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enobosarm extension in stress urinary incontinence
NCT03566290Phase 2Withdrawn
- Sponsor
- GTx
- Start
- Jun 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enobosarm in stress urinary incontinence (SUI), sponsored by GTx. Planned start Jun 2018; status: withdrawn.
02
Drugs
enobosarm
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT03566290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03566290.